Illumina Inc - Company Profile
Powered by 
All the data and insights you need on Illumina Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Illumina Inc Strategy Report
- Understand Illumina Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Illumina Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 11 Oct 2022 | Illumina Enters into Research Collaboration with AstraZeneca | Partnership | - |
AstraZeneca Plc Illumina Inc |
| 27 Jul 2022 | Neurolytic Healthcare (Mable) Raises USD3.2 Million in Seed Funding | Venture Financing |
First In Ventures LLC
Y Combinator, Inc.
Initialized Capital
Arkitekt Ventures
Illumina Inc
Inaki Berenguer
|
Neurolytic Healthcare Ltd
|
| 18 Jul 2022 | Delfi Diagnostics Raises USD225 Million in Series B Financing | Venture Financing |
Rock Springs Capital Management LP
Foresite Capital Management LLC
Illumina Ventures
PTX Capital
Point72 Ventures LLC
Orbimed Advisors LLC
Initiate Ventures
Eli Lilly and Co
Cowen Healthcare Investments
Osage University Partners
Open Field Capital LLC
Brown Advisory LLC
DFJ Growth Management, LLC
T Rowe Price Associates Inc
AV8 Ventures
Windham Venture Partners
Samsara BioCapital LLC
Point Field Partners LLC
Menlo Ventures
Northpond Ventures LLC
|
Delfi Diagnostics Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer